ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Washington University School of Medicine
Washington University School of Medicine
University of Iowa
Fox Chase Cancer Center
Wake Forest University Health Sciences
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Northwestern University
Alliance for Clinical Trials in Oncology
National Cancer Institute, Naples
Dartmouth-Hitchcock Medical Center
The University of Texas Health Science Center, Houston